A carregar...
Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system, and the most common cause of nontraumatic disability in young adults. Most patients have a relapsing–remitting course, and roughly half of them will eventually enter a degenerative progressive phase, marked...
Na minha lista:
| Publicado no: | Neurotherapeutics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722758/ https://ncbi.nlm.nih.gov/pubmed/28653282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0548-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|